Cleared Traditional

K210458 - OPTIS Mobile Next Imaging System

K210458 is the FDA 510(k) clearance for OPTIS Mobile Next Imaging System by Abbott Medical. It is a Class 2 Cardiovascular device (product code NQQ) cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K210458 · Abbott Medical · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2021
Decision
112d
Days
Class 2
Risk

K210458 is an FDA 510(k) clearance for the OPTIS Mobile Next Imaging System, OPTIS Integrated Next Imaging System. Classified as System, Imaging, Optical Coherence Tomography (oct) (product code NQQ), Class II - Special Controls.

Submitted by Abbott Medical (Westford, US). The FDA issued a Cleared decision on June 8, 2021 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 892.1560 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Medical devices

Submission Details

510(k) Number K210458 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 16, 2021
Decision Date June 08, 2021
Days to Decision 112 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d faster than avg
Panel avg: 125d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NQQ System, Imaging, Optical Coherence Tomography (oct)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
Definition This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - NQQ System, Imaging, Optical Coherence Tomography (oct)

All 23
Devices cleared under the same product code (NQQ) and FDA review panel - the closest regulatory comparables to K210458.
ILUMIEN™ OPTIS™ System, OPTIS™ Integrated System, OPTIS™ Mobile System, with AptiVue™ Imaging Software version E.6
K232386 · Abbott Medical · Sep 2023
HyperVue™ Imaging System
K230691 · Spectrawave, Inc. · Jun 2023
SpectraWAVE Imaging System
K221257 · Spectrawave, Inc. · Feb 2023
OTIS 2.1 Optical Coherence Tomography System, THiA Optical Coherence Tomography System
K203578 · Perimeter Medical Imaging Ai, Inc. · Feb 2021
ApolloVue S100 Image System
K201552 · Apollo Medical Optics, Ltd. · Sep 2020
Gentuity HF-OCT Imaging System with Vis-Rx Micro-Imaging Catheter
K192922 · Gentuity, LLC · Feb 2020